stud
bud
Sign up
Log in
Home
Library
Explore
SAT
More
Risk, Morbidity & Mortality Part I Flashcards | StudBud
Explore
/
Risk, Morbidity & Mortality Part I
Risk, Morbidity & Mortality Part I
28 terms
·
StudBud Administration
·
1 play
Imported from external platform
Flashcards
28 cards
F
Practice quiz
P
Host live
L
Questions
28
Answers
1
Undercounting certain groups in populations is an example of __.
Problems with Denominators
Problems with Numerators
2
Proportions are not rates
False
True
3
Which of the following stage is this: infection still present after clinical symptoms resolve- may reoccur
Subclinical
Persistent
Latent
Preclinical
4
If asked "Do you currently have asthma?" this is an example of
Incidence
Point Prevalence
Incidence Rate
Cumulative Incidence
5
For Case-Fatality, there is an explicit statement of time because they are generally used for acute diseases
False
True
6
Which of the following stage is this: infection w/ no multiplication ex.) viral genes present but no virus
Persistent
Latent
Preclinical
Subclinical
7
If asked "Have you ever had asthma?" this is an example of
Point Prevalence
Cumulative Incidence
Incidence
Incidence Rate
8
Which of the following are true regarding morbidity?
Medical problems caused by a treatment
Amount of death in a population
Having a disease or symptom of disease
Amount of disease in a population
9
Which of the following stage is this: No signs or symptoms but will progress
Subclinical
Persistent
Latent
Preclinical
10
All of the following are true in regards to Passive Surveillance
Data may be incomplete (voluntary) but is inexpensive
New versions include internet coupled data such as google searches
Responsibility falls on provider or public health offce
Available data is used/ Reportable Disease
11
Measure of event (transition from healthy to sick) is a measure of risk for incidence in a population
True
False
12
Median Survival Time is not as accurate or better than calculating the mean due to it being more affected by extremes
False
True
13
Hospitals that don't have defined populations is an example of __.
Problems with Denominators
Problems with Numerators
14
Overall most people in the population will seek care and hospitalization.
True
False
15
The Clinical Stage is when signs & symptoms show up
False
True
16
Survival Analysis allows scientists to incorporate info only in regards to the frequency of event occurrence
False
True
17
All of the following are true in regards to Active Surveillance
Data may be incomplete (voluntary) but is inexpensive
Available data is used/ Reportable Disease
Staff specifically carry out (case finding visits, record reviews)
More expensive but more accurate
18
__ year survival = % of patients who are alive after __ years after treatment begins or _ years after diagnosis
20
5
10
15
19
Finding cases: Pts are symptomatic but not seeking treatment/ Diagnosis not made/ Recall/Disclosures are examples of __.
Problems with Numerators
Problems with Denominators
20
"Women with hysterectomies can't get endometrial cancer" is an example of __.
Problems with Denominators
Problems with Numerators
21
If asked "Have you had asthma during the last (n) years?" this is an example of
Incidence Rate
Incidence
Point Prevalence
Cumulative Incidence
22
Prevalence = Incidence x Duration (this calculation is most accurate when prevalence is high)
True
False
23
Hospital data records not designed for research (missing data, variable diagnostic quality) is an example of __.
Problems with Denominators
Problems with Numerators
24
Prevalence = Incidence x Duration
False
True
25
Once an individual gets sick or is leave the study, they are out of the incidence denominator
False
True
26
Five Year Survival is a proportion and not a true rate that is influenced by screening programs
True
False
27
Deciding who has the disease (Diagnosis Criteria/ Case Definition Difference) is an example of ____.
Problems with Denominators
Problems with Numerators
28
Which of the following stage is this: No signs or symptoms but not destined to progress detectable by antibodies
Preclinical
Latent
Subclinical
Persistent